Official Publications NEOVACS

Equities

Real-time Euronext Paris Other stock markets 08:18:48 30/05/2024 BST			5-day change	1st Jan Change
0.1599 ^EUR	-6.27%		-6.60%	-92.00%

05-29	Neovacs: mRNA approach validated in preclinical trial	CF
05-27	Neovacs: collaboration contract with INSERM team	CF

Business information	05-26	CO
Mixed general shareholder meeting	05-23	CO
Mixed general Shareholders meeting notice	05-05	CO
Monthly statement on voting rights	04-29	CO
Financial report	04-29	CO
Annual results	04-29	CO
Monthly statement on voting rights	03-30	CO
Monthly statement on voting rights	02-13	CO
Business information	01-09	CO
Monthly statement on voting rights	12-30	CO
Reverse split	12-19	CO
Monthly statement on voting rights	11-29	CO
Monthly statement on voting rights	30/10/23	CO
1st-half-year results	30/10/23	CO
Half-year report	30/10/23	CO
Eligibility to PEA-PME (FR)	29/10/23	CO
Monthly statement on voting rights	29/09/23	CO
Monthly statement on voting rights	30/08/23	CO
Monthly statement on voting rights	29/06/23	CO
Shareholders meeting voting results	29/06/23	CO
Business information	18/06/23	CO
Combined general shareholders meeting	23/05/23	CO
Annual results	01/05/23	CO
Financial report	29/04/23	CO
Monthly statement on voting rights	30/03/23	CO